Foghorn Therapeutics (FHTX) Debt Ratio (2019 - 2021)
Foghorn Therapeutics' Debt Ratio came in at 0.08 for Q4 2020, down 88.6% from 0.68 a year earlier and down 26.0% from the prior quarter.
Powered by 
Analysis
Foghorn Therapeutics (FHTX) Debt Ratio (2019 - 2021) Analysis & Trends
- Going back by year, Debt Ratio was 0.68 in FY2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 0.39 |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 0.24 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 0.52 |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 0.42 |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 0.08 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 0.28 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 0.60 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 0.53 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 0.31 |
| 10 | Foghorn Therapeutics | 142.67 Mn | -183.28 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 0.11 |
| Jun 30, 2021 | 0.10 |
| Mar 31, 2021 | 0.09 |
| Dec 31, 2020 | 0.08 |
| Sep 30, 2020 | 0.10 |
| Dec 31, 2019 | 0.68 |
API Access
Foghorn Therapeutics Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=FHTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "FHTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=FHTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();